A regional blood bank is participating in a new trial that could help COVID-19 patients recover.
LifeSouth is partnering with medical centers in Florida, Georgia, and Alabama to collect plasma from COVID-19 patients who have recovered from the virus, to transfuse to patients who still have it.
The treatment is considered an investigational new drug by the FDA and collected donations will be sent to medical centers to treat critically ill COVID-19 patients. The plasma contains antibodies that may help fight the virus.
Recovered COVID-19 patients who were tested and found positive, can donate plasma if they have not had symptoms for at least 14 days and test negative by a lab, or after 28 days without symptoms with no follow-up testing required.
Potential donors should email [email protected] or call 888-795-2707.
